Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|April 21, 2020
Targeting Rho GTPase Signaling Networks in CancerNatasha S Clayton, Anne J RidleyFrontiers in Genetics|November 9, 2018
Emerging Roles of Fibroblast Growth Factor 10 in CancerNatasha S Clayton, Richard P GroseJournal of Cell Science|January 5, 2024
RhoU forms homo-oligomers to regulate cellular responsesNatasha S Clayton, Richard G Hodge, Elvira Infante, et al.The Journal of Biological Chemistry|June 24, 2016
Inhibition of Ral GTPases Using a Stapled Peptide ApproachJemima C Thomas, Jonathan M Cooper, Natasha S Clayton, et al.Scientific Reports|December 6, 2025
A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imagingHenrik Rehnstrom, Arthur Eley, Natasha S Clayton, et al.International Journal of Molecular Sciences|April 13, 2023
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 InductionNatasha S Clayton, Edward P Carter, Abbie E Fearon, et al.The Journal of Biological Chemistry|April 16, 2022
Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACKNatasha S Clayton, Millie Fox, Jose J Vicenté-Garcia, et al.Frontiers in Immunology|January 30, 2023
Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibitionFabiola González-Herrera, Natasha S Clayton, Daniela Guzmán-Rivera, et al.European Journal of Pharmacology|November 30, 2024
Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cellsJean Carlos Lipreri da Silva, Keli Lima, Benjamin Ede, et al.Cell Reports|March 1, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.Pageof 1